Mydecine Innovations Group Inc.

Mydecine Announces First Quarter 2022 Financial Results and Highlights

DENVER, May 16, 2022 -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (β€œMydecine” or the β€œCompany”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results and provided a business update for the first quarter of 2022.Β  β€œOur team had an ext... Read More...